These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15193913)

  • 1. RNA interference as a new strategy against viral hepatitis.
    Radhakrishnan SK; Layden TJ; Gartel AL
    Virology; 2004 Jun; 323(2):173-81. PubMed ID: 15193913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunities for treating chronic hepatitis B and C virus infection using RNA interference.
    Arbuthnot P; Longshaw V; Naidoo T; Weinberg MS
    J Viral Hepat; 2007 Jul; 14(7):447-59. PubMed ID: 17576386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference--small RNAs effectively fight viral hepatitis.
    Shlomai A; Shaul Y
    Liver Int; 2004 Dec; 24(6):526-31. PubMed ID: 15566500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of RNAi in the treatment of HCV infection.
    Volarevic M; Smolic R; Wu CH; Wu GY
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):823-31. PubMed ID: 17914916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
    Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
    Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interfering with hepatitis C virus RNA replication.
    Randall G; Rice CM
    Virus Res; 2004 Jun; 102(1):19-25. PubMed ID: 15068876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hepatitis B virus replication by recombinant small interfering RNAs.
    Wu K; Gong Y; Zhang X; Zhang Y; Mu Y; Liu F; Song D; Zhu Y; Wu J
    Acta Virol; 2005; 49(4):235-41. PubMed ID: 16402680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biology of viral hepatitis and hepatocellular carcinoma.
    Hayashi PH; Zeldis JB
    Compr Ther; 1993; 19(5):188-96. PubMed ID: 8275664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice.
    Shin D; Kim SI; Kim M; Park M
    Virus Res; 2006 Aug; 119(2):146-53. PubMed ID: 16443303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice.
    Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF
    Chin Med J (Engl); 2005 Aug; 118(16):1351-6. PubMed ID: 16157029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting the RNA interference pathway to counter hepatitis B virus replication.
    Arbuthnot P; Carmona S; Ely A
    Liver Int; 2005 Feb; 25(1):9-15. PubMed ID: 15698393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of chronic hepatitis B virus infection: a promising approach using small interfering RNA (siRNA).
    Dwivedi M; Misra SP; Misra V; Waikhom RK; Bhatnagar M
    Natl Med J India; 2008; 21(3):123-7. PubMed ID: 19004143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The silent treatment: RNAi as a defense against virus infection in mammals.
    van Rij RP; Andino R
    Trends Biotechnol; 2006 Apr; 24(4):186-93. PubMed ID: 16503061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic short hairpin RNA expression in the liver: viral targets and vectors.
    Grimm D; Kay MA
    Gene Ther; 2006 Mar; 13(6):563-75. PubMed ID: 16453009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escape from the interferon response associated with RNA interference using vectors that encode long modified hairpin-RNA.
    Akashi H; Miyagishi M; Yokota T; Watanabe T; Hino T; Nishina K; Kohara M; Taira K
    Mol Biosyst; 2005 Dec; 1(5-6):382-90. PubMed ID: 16881007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential applications of siRNA in hepatitis C virus therapy.
    Smolic R; Volarevic M; Wu CH; Wu GY
    Curr Opin Investig Drugs; 2006 Feb; 7(2):142-6. PubMed ID: 16499284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCV core protein interacts with Dicer to antagonize RNA silencing.
    Chen W; Zhang Z; Chen J; Zhang J; Zhang J; Wu Y; Huang Y; Cai X; Huang A
    Virus Res; 2008 May; 133(2):250-8. PubMed ID: 18325616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA interference against hepatitis B virus with endoribonuclease-prepared siRNA despite of the target sequence variations.
    Tan C; Xuan B; Hong J; Dai Z; Hao R; Li Z; Huang W
    Virus Res; 2007 Jun; 126(1-2):172-8. PubMed ID: 17399837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic application of RNA interference for hepatitis C virus.
    Watanabe T; Umehara T; Kohara M
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1263-76. PubMed ID: 17822803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.